Strategies for improved targeting of therapeutic cells: Implications for tissue repair

European Cells and Materials

Volumn 23, Issue , 2012, Pages 310-319

  Ansboro, Sharon ^a   Greiser, Udo ^a   Barry, Frank ^a   Murphy, Mary ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Cartilage repair; Cell surface markers; Chondrocytes; Mesenchymal stem cells; Nanoparticles; Osteoarthritis; Regenerative medicine; Targeting approaches

Indexed keywords

NANOPARTICLE;

CELL HOMING; CELL SURFACE; CELL SURFACE MODIFICATION; CLINICAL EFFECTIVENESS; ENGRAFTMENT; HUMAN; IMAGING; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NANOTECHNOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSTEOARTHRITIS; REVIEW; STEM CELL GENE THERAPY; STEM CELL NICHE; TARGET CELL; TISSUE ENGINEERING; TISSUE REPAIR;

EID: 84865548092     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v023a24     Document Type: Review

References (65)

1. Ai HC, Hong JS, Yu Z, Gao JT (2009) In vivo tracking of dual-labeled mesenchymal stem cells homing into the injured common carotid artery. Anat Rec 292: 1677-1683.
2. Arias JL (2011) Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging. Expert Opin Drug Deliv 8: 589-1608.
3. Balyasnikova IV, Ferguson SD, Sengupta S, Han Y, Lesniak MS (2010) Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma. PLoS One 5: e9750.
4. Berg EL, McEvoy LM, Berlin C, Bargatze RF, Butcher EC (1993) L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 366: 695-698.
5. Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, Holzmann B, Weissman IL, Hamann A, Butcher EC (1993) Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74: 185-195.
6. Bouffi C, Thomas O, Bony C, Giteau A, Venier-Julienne C, Jorgensen C, Montero-Menei C, Noel D (2010) The role of pharmacologically active microcarriers releasing TGF-beta3 in cartilage formation in vivo by mesenchymal stem cells. Biomaterials 31: 6485-6493.
7. Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9: 11-15.
8. Chen WY, Abatangelo G (1999) Functions of hyaluronan in wound repair. Wound Repair Regen 7: 79-89.
9. Cheng K, Li TS, Malliaras K, Davis DR, Zhang Y, Marban E (2010) Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 106: 1570-1581.
10. Cheng Z, Ou L, Zhou X, Li F, Jia X, Zhang Y, Liu X, Li Y, Ward CA, Melo LG, Kong D (2008) Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 16: 571-579.
11. Chorny M, Fishbein I, Forbes S, Alferiev I (2011) Magnetic nanoparticles for targeted vascular delivery. IUBMB Life 63: 613-620.
12. Coleman CM, Curtin C, Barry FP, O'Flatharta C, Murphy JM (2010) Mesenchymal stem cells and osteoarthritis: Remedy or accomplice? Human Gene Therapy 21: 1239-1250.
13. Curley GF, Hayes M, Ansari B, Shaw G, Ryan A, Barry F, O'Brien T, O'Toole D, Laffey JG (2011) Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax, in press.
14. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44: 1928-1942.
15. Dennis JE, Cohen N, Goldberg VM, Caplan AI (2004) Targeted delivery of progenitor cells for cartilage repair. J Orthop Res 22: 735-741.
16. Dwyer RM, Ryan J, Havelin RJ, Morris JC, Miller BW, Liu Z, Flavin R, O'Flatharta C, Foley MJ, Barrett HH, Murphy JM, Barry FP, O'Brien T, Kerin MJ (2011) Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer. Stem Cells 29: 1149-1157.
17. Egusquiaguirre SP, Igartua M, Hernandez RM, Pedraz JL (2012) Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research. Clin Transl Oncol 14: 83-93.
18. Frenette PS, Subbarao S, Mazo IB, von Andrian UH, Wagner DD (1998) Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci U S A 95: 14423-14428.
19. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, Palasis M, Wilensky RL (2006) A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27: 1114-1122.
20. Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE (2012) Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 18: 456-462.
21. Herranz F, Almarza E, Rodriguez I, Salinas B, Rosell Y, Desco M, Bulte JW, Ruiz-Cabello J (2011) The application of nanoparticles in gene therapy and magnetic resonance imaging. Microsc Res Tech 74: 577-591.
22. Hori J, Deie M, Kobayashi T, Yasunaga Y, Kawamata S, Ochi M (2011) Articular cartilage repair using an intraarticular magnet and synovium-derived cells. J Orthop Res 29: 531-538.
23. Huang DM, Hung Y, Ko BS, Hsu SC, Chen WH, Chien CL, Tsai CP, Kuo CT, Kang JC, Yang CS, Mou CY, Chen YC (2005) Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: Implication for stem cell tracking. FASEB J 19: 2014-2016.
24. Hunziker EB, Rosenberg LC (1996) Repair of partialthickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am 78: 721-733.
25. Jing XH, Yang L, Duan XJ, Xie B, Chen W, Li Z, Tan HB (2008) In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine 75: 432-438.
26. Katayama Y, Hidalgo A, Furie BC, Vestweber D, Furie B, Frenette PS (2003) PSGL-1 participates in E-selectinmediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood 102: 2060-2067.
27. Kean TJ, Duesler L, Young RG, Dadabayev A, Olenyik A, Penn M, Wagner J, Fink DJ, Caplan AI, Dennis JE (2012) Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell. J Drug Target 20: 23-32.
28. Kim JH, Park JS, Yang HN, Woo DG, Jeon SY, Do HJ, Lim HY, Kim JM, Park KH (2011) The use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis. Biomaterials 32: 268-278.
29. Ko IK, Kean TJ, Dennis JE (2009) Targeting mesenchymal stem cells to activated endothelial cells. Biomaterials 30: 3702-3710.
30. Ko IK, Kim BG, Awadallah A, Mikulan J, Lin P, Letterio JJ, Dennis JE (2010) Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther 18: 1365-1372.
31. Komarova S, Roth J, Alvarez R, Curiel D, Pereboeva L (2010) Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor. J Ovar Res 3: 12.
32. Kraus VB, Burnett B, Coindreau J, Cottrell S, Eyre D, Gendreau M, Gardiner J, Garnero P, Hardin J, Henrotin Y, Heinegard D, Ko A, Lohmander LS, Matthews G, Menetski J, Moskowitz R, Persiani S, Poole AR, Rousseau JC, Todman M (2011) Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage 19: 515-542.
33. Kumar S, Ponnazhagan S (2007) Bone homing of mesenchymal stem cells by ectopic {alpha}4 integrin expression. FASEB J 21: 3917-3927.
34. Kumari A, Yadav SK (2011) Cellular interactions of therapeutically delivered nanoparticles. Expert Opin Drug Deliv 8: 141-151.
35. Laroui H, Grossin L, Leonard M, Stoltz JF, Gillet P, Netter P, Dellacherie E (2007) Hyaluronate-covered nanoparticles for the therapeutic targeting of cartilage. Biomacromolecules 8: 3879-3885.
36. Lee CH, Cook JL, Mendelson A, Moioli EK, Yao H, Mao JJ (2010) Regeneration of the articular surface of the rabbit synovial joint by cell homing: A proof of concept study. The Lancet, 376: 440-448.
37. Lee RJ, Fang Q, Davol PA, Gu Y, Sievers RE, Grabert RC, Gall JM, Tsang E, Yee MS, Fok H, Huang NF, Padbury JF, Larrick JW, Lum LG (2007) Antibody Targeting of Stem Cells to Infarcted Myocardium. Stem Cells 25: 712-717.
38. Li J, Feng L, Fan L, Zha Y, Guo L, Zhang Q, Chen J, Pang Z, Wang Y, Jiang X, Yang VC, Wen L (2011) Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. Biomaterials 32: 4943-4950.
39. Liu X, Jin X, Ma PX (2011) Nanofibrous hollow microspheres self-assembled from star-shaped polymers as injectable cell carriers for knee repair. Nat Mater 10: 398-406.
40. Loebinger MR, Kyrtatos PG, Turmaine M, Price AN, Pankhurst Q, Lythgoe MF, Janes SM (2009) Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 69: 8862-8867.
41. Minas T, Gomoll AH, Solhpour S, Rosenberger R, Probst C, Bryant T (2010) Autologous chondrocyte implantation for joint preservation in patients with early osteoarthritis. Clin Orthop Relat Res 468: 147-157.
42. Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ (2011) Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 50: 280-289.
43. Murashita T, Nakayama Y, Hirano T, Ohashi S (1996) Acceleration of granulation tissue ingrowth by hyaluronic acid in artificial skin. Br J Plast Surg 49: 58-63.
44. Murphy JM, Fink DJ, Hunziker EB, Barry FP (2003) Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48: 3464-3474.
45. Nöth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS (2002) Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthopaed Res 20: 1060-1069.
46. Ossendorf C, Steinwachs MR, Kreuz PC, Osterhoff G, Lahm A, Ducommun PP, Erggelet C (2011) Autologous chondrocyte implantation (ACI) for the treatment of large and complex cartilage lesions of the knee. Sports Med Arthrosc Rehabil Ther Technol 3: 11.
47. Park JS, Na K, Woo DG, Yang HN, Kim JM, Kim JH, Chung HM, Park KH (2010) Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells. Biomaterials 31: 124-132.
48. Park JS, Yang HN, Woo DG, Jeon SY, Do HJ, Lim HY, Kim JH, Park KH (2011) Chondrogenesis of human mesenchymal stem cells mediated by the combination of SOX trio SOX5, 6, and 9 genes complexed with PEI modified PLGA nanoparticles. Biomaterials 32: 3679-3688.
49. Parveen S, Misra R, Sahoo SK (2012) Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 8: 147-166.
50. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
51. Rothenfluh DA, Bermudez H, O'Neil CP, Hubbell JA (2008) Biofunctional polymer nanoparticles for intraarticular targeting and retention in cartilage. Nat Mater 7: 248-254.
52. Ruegg C, Alghisi GC (2010) Vascular integrins: therapeutic and imaging targets of tumor angiogenesis. Recent Results Cancer Res 180: 83-101.
53. Sackstein R (2012) Glycoengineering of HCELL, the human bone marrow homing receptor: Sweetly programming cell migration. Ann Biomed Eng 40: 766-776.
54. Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, Wohlgemuth R (2008) Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 14: 181-187.
55. Sarkar D, Vemula PK, Zhao W, Gupta A, Karnik R, Karp JM (2010) Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting. Biomaterials 31: 5266-5274.
56. Sarkar D, Ankrum JA, Teo GSL, Carman CV, Karp JM (2011) Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrinelike mechanisms. Biomaterials 32: 3053-3061.
57. Sharma M, Afrin F, Satija N, Tripathi RP, Gangenahalli GU (2011) Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev 20: 933-946.
58. Song C, Li G (2011) CXCR4 and matrix metalloproteinase-2 are involved in mesenchymal stromal cell homing and engraftment to tumors. Cytotherapy 13: 549-561.
59. Tanida S, Mizoshita T, Mizushima T, Sasaki M, Shimura T, Kamiya T, Kataoka H, Joh T (2011) Involvement of oxidative stress and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in inflammatory bowel disease. J Clin Biochem Nutr 48: 112-116.
60. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W, Ho AD (2005) Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416.
61. Wilson T, Stark C, Holmbom J, Rosling A, Kuusilehto A, Tirri T, Penttinen R, Ekholm E (2010) Fate of bone marrow-derived stromal cells after intraperitoneal infusion or implantation into femoral bone defects in the host animal. J Tissue Eng, 2010: 345806.
62. Yang F, Cho SW, Son SM, Bogatyrev SR, Singh D, Green JJ, Mei Y, Park S, Bhang SH, Kim BS, Langer R, Anderson DG (2010) Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci USA 107: 3317-3322.
63. Yoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E, Sato K, Inoue K, Nagase T, Koshima I, Gonda K (2006) Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 208: 64-76.
64. Zanjani ED, Flake AW, Almeida-Porada G, Tran N, Papayannopoulou T (1999) Homing of human cells in the fetal sheep model: modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function. Blood 94: 2515-2522.
65. Zischek C, Niess H, Ischenko I, Conrad C, Huss R, Jauch KW, Nelson PJ, Bruns C (2009) Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma. Ann Surg 250: 747-752.